Nodality has a documented Quality System to help assure compliance with FDA regulations, CLIA and HIPAA requirements and other applicable regulations. Our Quality System includes procedures and specifications for the preparation of test reagents, control of instrumentation, and control and monitoring of process parameters.
Nodality has a Quality Policy which reflects the company's commitment to providing innovative testing solutions for hematological and autoimmune disorders, including biomarker identification and analysis, drug discovery research and development, patient stratification, and monitoring the pharmacodynamics of therapeutics.
Quality Policy:
“Nodality is committed to providing medical and research communities with innovative solutions that offer clear guidance to physicians and patients facing challenging therapeutic decisions via the development, manufacture and delivery of safe, effective and reliable clinical assays and information products.”